Join the fight to achieve global malaria elimination targets
Donate today and join the fight to achieve global malaria elimination targets.
Together we can make a significant contribution to achieving malaria elimination targets.
Donate today and join the fight to achieve global malaria elimination targets.
Together we can make a significant contribution to achieving malaria elimination targets.
By understanding the causes of persistent immune activation and chronic inflammation in HIV patients, we aim to develop prognostic tools and adjunctive therapies to predict and improve health outcomes.
HIV infection is a chronic viral infection which can be managed using combination antiretroviral therapy such that progression to AIDS is greatly minimised. Long term management of patients receiving antiretroviral therapy, especially their risk of non-AIDS co-morbidities, is a major concern.
Our group focuses on understanding the immune defects that persist in HIV+ patients receiving combination antiretroviral therapy, and how these contribute to decreased life expectancy and increased non-AIDS co-morbidities such as cardiovascular disease.
By understanding the causes of persistent immune activation and chronic inflammation in HIV patients, we aim to develop prognostic tools and adjunctive therapies to predict and improve health outcomes.
We study cells of the innate immune system (monocytes and natural killer cells) that are important to inflammation.
Deputy Program Director, Disease Elimination